Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits

Current Eye Research

Volumn 33, Issue 2, 2008, Pages 149-158

  Amar, Thierry ^a   Caillaud, Thierry ^a   Elena, Pierre Paul ^a  

^a Iris Pharma   (France)

Author keywords

Azithromycin; Conjunctivitis; Pharmacokinetics; Rabbit; Topical

Indexed keywords

AZITHROMYCIN; VISUAL PIGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONJUNCTIVA; CONJUNCTIVITIS; CORNEA; DRUG INSTILLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACRIMAL FLUID; MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; AQUEOUS HUMOR; AZITHROMYCIN; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CONJUNCTIVA; CORNEA; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; RABBITS; TEARS; TISSUE DISTRIBUTION;

EID: 39749097785     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680701860499     Document Type: Article

References (28)

1. Jaruratanasirikul S, Hortiwakul R, Tantisarasart T, Phuenpathom N, Tussanasunthornwong S. Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. Antimicrob Agents Chemother. 1996;40:825-826.
2. Retsema J, Girard A, Schelldy W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R. Spectrum and mode of action of azithromycin (CP-62, 993), a 15-membered ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987;31:1939-1947.
3. Wyrick PB, Davis CH, Knight ST, Choong J. In vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial cells. J Antimicrob Chemother. 1993;31:139-150.
4. Tabbara KF, al-Kharashi SA, al-Mansouri SM, al-Omar OM, Cooper H, el-Asrar AM, Foulds G. Ocular levels of azithromycin. Arch Ophthalmol. 1998;116:1625-1628.
5. Bowman RJC, Sillah A, van Dehn C, Goode VM, Muquit M, Johnson GJ, Milligan P, Rowley J, Faal H, Bailey RL. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000;41:4074-4079.
6. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342:453-456.
7. Chem KC, Shrestha SK, Cevallos V, Dhami HL, Tiwari P, Chem L, Whitcher JP, Lietman TM. Alterations in the conjunctival bacterial flora following a single dose of azithromycin in a trachoma endemic area. Br J Ophthalmol. 1999;83:1332-1335.
8. Scieux C, Bianchi A, Chappey B, Vassias I, Perol Y. In vitro activity of azithromycin against Chlamydia trachomatis. J Antimicrob Chemother. 1990;25(Suppl A):7-10.
9. Slaney L, Chubb H, Ronald A, Brunham R. In vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis. J Antimicrob Chemother. 1990;25(Suppl A):1-5.
10. Drew RH, Gallis HA. Azithromycin-spectrum of activity, pharmacokinetics, and clinical applications. Pharmacotherapy. 1992;12:161-173.
11. Fechner PU, Teichmann KD. Chemotherapy of bacterial infections. In: Fechner PU, Teichmann KD, eds. Ocular therapeutics. Pharmacology and Clinical Application. Thorofare, NJ. Slack Incorporated. 1998;2:15-44.
12. Barry AL, Jones RN, Thornsberry C. In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-0.31), erythromycin, roxithromycin, and clindamycin. Antimicrob Agents Chemother. 1998;32:752-754.
13. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brennan L, Mason R. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother. 1987;31:1939-1947.
14. Peters DH, Friedel HA, McTavish D. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1992;44:750-799.
15. Carbon C, Poole MD. The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data. J Chemother. 1999;11:107-118.
16. Barry AL, Fuchs PC, Brown SD. Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother. 1997;40:139-140.
17. Zuckerman JM. Macolides and ketolides: Azithromycin, clarithromycin, telithromycin. Infect Dis Clin North Am. 2004;18:621-649.
18. Thomson KS, Chartrand SA, Sanders CC, Block S. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus peumoniae. Antimicrob Agents Chemother. 1997;41:478-480.
19. Morrow GL, Abbott RL. Conjunctivitis. Am Fam Physician. 1998;57:735-746.
20. Soukiasian SH, Baum J. Bacterial conjunctivitis. 2nd Edition. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea. Philadelphia, PA: Elsevier Mosby; 2005: 615-628.
21. Syed NA, Chandler JW. Bacterial conjunctivitis. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye. Boston, MA: Little, Brown and Co; 1996: 423-431.
22. Ben Ali F, Golstein FW, Acar JF. In vitro activity of macrolides against traditional susceptible bacteria. In: Schonfeld W, Kirst HA, eds. Macrolide Antibiotics. Basel, Switzerland: Birkhaüse Verlag; 2002:185-200.
23. Gigliotti F, Williams WT, Hayden FG, Hendley JO, Benjamin J, Dickens M, Gleason C, Perriello VA, Wood J. Etiology of acute conjunctivitis in children. J Pediatr. 1981;98:531-536.
24. Gross RD, Hoffman RO, Lindsay RN. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children. Clin Pediatr (Phila). 1997;36:435-444.
25. World Health Organization. Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva, Switzerland, 30 June-1 July 1997; WHO/PBL/GET/97: 1-33.
26. O'Day D, Head WS, Foulds G, Robinson RD, Williams TE, Ferraina RA. Ocular pharmacokinetics of orally administered azithromycin in rabbits. J Ocular Pharmacol. 1994;10:633-641.
27. Karcioglu ZA, Ahmed WS, Raines D, Al-Yazigi A. Pharmacokinetics of azithromycin in rabbit lacrimal glands and conjunctiva. Ophthalmic Res.1999:31:47-52.
28. Tabbara KF, El-Asrar AMA, Al-Omar O, Choudhury AH, al-Faisal Z. Single-dose azithromycin in the treatment of trachoma. Ophthalmology. 1996;103:842-846.